drugset / Trial / NCT03422796

The Effect of Sumatriptan and Placebo Injection on Cilostazol Induced Headache

NCT03422796

Completed 30 enrolled Danish Headache Center
RandomizedCrossoverDouble-blindTreatment

Summary

To develop a pragmatic migraine model the investigators will induce headache in patients with migraine without aura with a phosphodiesterase inhibitor (cilostazol). If the headache responds to sumatriptan injection, the model can be used to test new drug candidates.

Timeline

Start
2017-11-01
Primary completion
2018-09-01
Completion
2018-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sumatriptan Unknown 6 mg/ml Subcutaneous
Comparator Cilostazol Small molecule 200 mg

Indications